TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2024 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
TENX on Nasdaq
Shares outstanding
6,999,586
Price per share
$13.37
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,948,962
Total reported value
$84,695,343
% of total 13F portfolios
0%
Share change
+2,212,928
Value change
+$29,084,194
Number of holders
47
Price from insider filings
$13.37
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vestal Point Capital, LP 9.9% $18,525,720 2,470,096 Vestal Point Capital, LP 30 Sep 2024
Ikarian Capital, LLC 16% -27% $6,473,244 967,600 0% Ikarian Capital, LLC 30 Nov 2025
BIOTECHNOLOGY VALUE FUND L P 10% $11,561,410 768,200 BVF PARTNERS L P/IL 31 Dec 2025
Venrock Healthcare Capital Partners III, L.P. 9.9% 0% $10,429,033 +$2,106,834 692,959 +25% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
RTW INVESTMENTS, LP 9.9% -0.9% $9,797,068 +$3,499,546 650,968 +56% RTW Investments, LP 31 Dec 2025
JANUS HENDERSON GROUP PLC 10% +150% $4,172,774 +$3,057,778 623,733 +274% JANUS HENDERSON GROUP PLC 28 Nov 2025
MORGAN STANLEY 9.6% $8,975,459 596,376 Morgan Stanley 31 Dec 2025
PERCEPTIVE ADVISORS LLC 9.1% +30% $8,568,085 +$1,958,998 569,308 +30% Perceptive Advisors LLC 31 Dec 2025
Lind Global Fund II LP 6.6% -24% $6,659,324 442,480 0% Lind Global Fund II LP 31 Dec 2025
Invus Global Management, LLC 9.4% $2,562,846 427,141 Raymond Debbane 26 Sep 2025
Point72 Asset Management, L.P. 6.8% -8.6% $6,372,396 +$1,260,919 423,415 +25% Point72 Asset Management, L.P. 31 Dec 2025
Dellora Investments LP 6.4% -27% $6,036,119 +$752,500 401,071 +14% Dellora Investments LP 31 Dec 2025
INTEGRATED CORE STRATEGIES (US) LLC 6.9% +22% $1,882,272 +$480,576 313,712 +34% Integrated Core Strategies (US) LLC 30 Sep 2025
S.H.N. Financial Investments Ltd. 5% $1,052,814 179,050 S.H.N. Financial Investments Ltd. 31 Dec 2024

As of 31 Dec 2025, 47 institutional investors reported holding 6,948,962 shares of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX). This represents 99% of the company’s total 6,999,586 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) together control 95% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Ikarian Capital, LLC 14% 967,600 0% 1.5% $11,795,044
MORGAN STANLEY 8.5% 596,376 +234% 0% $7,269,823
PERCEPTIVE ADVISORS LLC 6.3% 439,142 0.1% $5,353,141
Siren, L.L.C. 6.1% 427,141 +21% 0.16% $5,206,849
Point72 Asset Management, L.P. 6% 423,415 0.01% $5,161,429
RTW INVESTMENTS, LP 5.4% 378,346 0% 0.05% $4,612,038
BOOTHBAY FUND MANAGEMENT, LLC 5% 352,206 0% 0.11% $4,293,391
BVF INC/IL 4.9% 339,549 0% 0.14% $4,139,102
MILLENNIUM MANAGEMENT LLC 4.3% 302,473 -3.6% 0% $3,687,146
MARSHALL WACE, LLP 4.3% 298,153 +68% 0% $3,634,484
VANGUARD GROUP INC 3.7% 255,664 +58% 0% $3,116,545
DIADEMA PARTNERS LP 3.5% 243,170 1.8% $2,964,242
Vivo Capital, LLC 3% 208,333 0% 0.16% $2,539,579
SPHERA FUNDS MANAGEMENT LTD. 2.7% 190,111 0.48% $2,317,453
Integral Health Asset Management, LLC 2.4% 167,000 0% 0.1% $2,035,730
JANUS HENDERSON GROUP PLC 2.4% 166,666 0% 0% $2,019,159
Woodline Partners LP 2% 143,481 +63% 0.01% $1,749,033
FMR LLC 2% 141,100 0% $1,720,009
CITADEL ADVISORS LLC 1.9% 129,528 +199% 0% $1,578,947
RENAISSANCE TECHNOLOGIES LLC 1.8% 125,579 +122% 0% $1,530,808
Velan Capital Investment Management LP 1.2% 83,333 0% 0.59% $1,015,829
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.2% 83,333 0% 0% $1,015,829
Persistent Asset Partners Ltd 0.93% 65,272 0.38% $795,666
ADAR1 Capital Management, LLC 0.91% 63,673 +19% 0.06% $776,174
GEODE CAPITAL MANAGEMENT, LLC 0.8% 55,699 +62% 0% $678,970

Institutional Holders of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,948,962 $84,695,343 +$29,084,194 $12.19 47
2025 Q3 4,720,738 $35,929,590 +$18,970,343 $7.61 34
2025 Q2 2,231,961 $12,926,914 +$1,314,380 $5.76 25
2025 Q1 2,006,422 $13,111,231 +$4,224,591 $6.55 23
2024 Q4 1,362,190 $8,426,122 +$1,144,778 $6.19 21
2024 Q3 1,228,920 $4,253,022 +$4,189,827 $3.46 19
2024 Q2 18,829 $57,207 +$35,228 $3.02 10
2024 Q1 7,235 $30,532 +$30,532 $4.24 9